drugset / Trial / NCT05728879

Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution

NCT05728879 ↗

Phase 0 Not yet recruiting 30 enrolled Northwestern University
NaSingle-groupOpen-labelTreatment

Summary

This open-label, pilot study will evaluate the tolerance and change in the microbiome from the use of APR-TD011 ((RLF-TD011) wound cleansing spray for the treatment of CTCL skin lesions.

Timeline

Start
2027-01
Primary completion
2028-12
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Subject APR-TD011 Other / unclassified — —